Alpha 2.0
Login Register
» Authors » Yingjun Bao

Yingjun Bao

Explore the profile of Yingjun Bao including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 9
Followers 0
Related Specialties
General Medicine
General Surgery
Pharmacology
Top 10 Co-Authors
Kimberly H Nguyen
Weixin Ren
Weizheng Ji
Diwen Zhu
Gengfei Cao
Haixiao Zhang
Junpeng Gu
Laura Corlin
Julie Mortazavi
Robert A Bednarczyk
Published In
Vaccines (Basel)
Ann Palliat Med
Am J Health Promot
Med Sci Monit
J Gastrointest Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
Quantitative evaluation of liver perfusion dynamics with Technetium-99m phytate: A peripheral IV approach to pre- and post-TIPS analysis
Zhang Y, Bao Y, Yerjiang A, Ren W
Asian J Surg . 2024 Oct; PMID: 39353782
No abstract available.
2.
Transarterial chemoembolization using drug-eluting beads versus lipiodol in the treatment of unresectable hepatocellular carcinoma: propensity score matching
Cao G, Gu J, Zhang H, Ji W, Zhu D, Bao Y, et al.
J Gastrointest Oncol . 2024 Jul; 15(3):1101-1111. PMID: 38989437
Background: Since the introduction of drug-eluting beads (DEB), the result comparing transarterial chemoembolization (TACE) using lipiodol, also called conventional transarterial chemoembolization (c-TACE), and DEB-TACE shows considerable controversy. The objective of...
3.
Prior COVID-19 Diagnosis, Severe Outcomes, and Long COVID among U.S. Adults, 2022
Nguyen K, Bao Y, Chen S, Bednarczyk R, Vasudevan L, Corlin L
Vaccines (Basel) . 2024 Jun; 12(6). PMID: 38932398
Given the increase in COVID-19 emergency department visits and hospitalizations during the winter of 2023-2024, identifying groups that have a high prevalence of COVID-19 cases, severity, and long-term symptoms can...
4.
Reasons for COVID-19 Non-Vaccination from 2021 to 2023 for Adults, Adolescents, and Children
Nguyen K, Bao Y, Mortazavi J, Corlin L, Allen J
Vaccines (Basel) . 2024 Jun; 12(6). PMID: 38932297
Understanding how attitudes and beliefs about COVID-19 vaccination have changed over time is essential for identifying areas where targeted messaging and interventions can improve vaccination confidence and uptake. Using data...
5.
COVID-19 Diagnosis, Severity, and Long COVID Among U.S. Adolescents, National Health Interview Survey, 2022
Nguyen K, Chen S, Bao Y, Lu Y, Bednarczyk R, Vasudevan L
Am J Health Promot . 2024 Feb; 38(4):534-539. PMID: 38311899
Purpose: Understanding disparities in COVID-19 outcomes, overall and stratified by vaccination status, is important for developing targeted strategies to increase vaccination coverage and protect adolescents from COVID-19. Design: The 2022...
6.
Prevalence and Factors Associated with Long COVID Symptoms among U.S. Adults, 2022
Nguyen K, Bao Y, Mortazavi J, Allen J, Chocano-Bedoya P, Corlin L
Vaccines (Basel) . 2024 Jan; 12(1). PMID: 38250912
Long COVID and its symptoms have not been examined in different subpopulations of U.S. adults. Using the 2022 BRFSS (n = 445,132), we assessed long COVID and each symptom by...
7.
Curative Analysis of Patients with Hepatocellular Carcinoma Using Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation
Li Y, Zhu D, Ren W, Gu J, Ji W, Zhang H, et al.
Med Sci Monit . 2022 Jun; 28:e936246. PMID: 35652149
BACKGROUND Transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) can improve the survival of patients with hepatocellular carcinoma (HCC). The purpose was to explore the characteristics of high-risk and...
8.
Vascular normalization therapy with targeted localized vessel bevacizumab infusion in hepatocellular carcinoma after transarterial chemoembolization failure
Zhang H, Cao G, Ren W, Gu J, Ji W, Zhu D, et al.
Ann Palliat Med . 2021 Sep; 10(8):9149-9156. PMID: 34488400
Background: Hepatocellular carcinoma (HCC) is a highly vascularized tumor in which abnormal blood vessels contribute to poor treatment efficacy and prognosis. In this study, we assessed the efficacy, safety, and...